Alkem Laboratories informs about press release

15 Mar 2021 Evaluate

Alkem Laboratories has informed that Company has launched Brivaracetam in India under the brand name ‘Brivasure’, an affordable anti-epileptic drug for the treatment of Epilepsy in India. Brivasure has received authorization from the Drug Controller General of India (DCGI). In this regard, the company has enclosed a press release on 15th March 2021 titled ‘Alkem makes epilepsy treatment more accessible & affordable with the launch of Brivasure (Brivaracetam)’.

The above information is a part of company’s filings submitted to BSE.

Alkem Laboratories Share Price

5744.35 2.50 (0.04%)
20-Jan-2026 10:13 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1663.00
Dr. Reddys Lab 1166.00
Cipla 1380.00
Zydus Lifesciences 881.95
Lupin 2162.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×